LIOTHYRONINE SODIUM | THYROXINE SODIUM | METHYLTESTOSTERONE | STILBOESTROL - Resultados da pesquisa

teva-liothyronine tablet

teva canada limited - liothyronine (liothyronine sodium) - tablet - 5mcg - liothyronine (liothyronine sodium) 5mcg - thyroid agents

Canadá - inglês - Health Canada

teva-liothyronine tablet

teva canada limited - liothyronine (liothyronine sodium) - tablet - 25mcg - liothyronine (liothyronine sodium) 25mcg - thyroid agents

Estados Unidos - inglês - NLM (National Library of Medicine)

thyrolar- liothyronine sodium, levothyroxine sodium tablet

allergan, inc. - liothyronine sodium (unii: gca9vv7d2n) (liothyronine - unii:06lu7c9h1v), levothyroxine sodium (unii: 9j765s329g) (levothyroxine - unii:q51bo43mg4) - liothyronine 3.1 ug - thyrolar tablets are indicated: - as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. this category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (see warnings ). - as pituitary tsh suppressants, in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, sub-acute or chronic iymphocytic thyroiditis (hashimoto's), multinodular goiter, and in the management of thyroid cancer. thyroid hormone preparations are generally contraindicated in patients with diagnosed but as yet uncorrected adr